Pushpendra Singh

and 2 more

Mathematics is the foundational discipline for all sciences, engineering, and technology, and the pursuit of a normed division algebra of all finite dimensions represents a paramount mathematical objective. In the quest for a real three-dimensional, normed, associative division algebra, Hamilton discovered quaternions, constituting a non-commutative division algebra of quadruples. Subsequent investigations revealed the existence of only four division algebras over reals, each with dimensions 1, 2, 4, and 8. This study transcends such limitations by introducing generalized hypercomplex numbers extending across all dimensions, serving as extensions of traditional complex numbers. The space formed by these numbers constitutes a non-distributive normed division algebra extendable to all finite dimensions. The derivation of these extensions involves the definitions of two new $\pi$-periodic functions and a unified multiplication operation, designated as spherical multiplication, that is fully compatible with the existing multiplication structures. Importantly, these new hypercomplex numbers and their associated algebras are compatible with the existing real and complex number systems, ensuring continuity across dimensionalities. Most importantly, like the addition operation, the proposed multiplication in all dimensions forms an Abelian group while simultaneously preserving the norm. In summary, this study presents a comprehensive generalization of complex numbers and the Euler identity in higher dimensions, shedding light on the geometric properties of vectors within these extended spaces. Finally, we elucidate the practical applications of the proposed methodology as a viable alternative for expressing a quantum state through the multiplication of specified quantum states, thereby offering a potential complement to the established superposition paradigm. Additionally, we explore its utility in point cloud image processing.

Pushpendra Singh

and 4 more

Pushpendra Singh

and 2 more

Manu Shetty

and 9 more

Background and Purpose: Randomized Control Trials (RCTs) are the gold standard for establishing causality in drug efficacy, However, they have limitations due to strict inclusion criteria and complexity. When RCTs are not feasible, researchers turn to observational studies. Explainable AI (XAI) models provide an alternative approach to understanding cause-and-effect relationships. Experimental Approach: : In this study, we utilized an XAI model with a historical COVID-19 dataset to establish the hypothesis of drug efficacy. The datasets consisted of 3,307 COVID-19 patients from a hospital in Delhi, India. Eight XAI models were employed to assess factors influencing COVID-19 mortality. LIME and SHAP interpretability techniques were applied to the best-performing ML model to determine feature importance in outcome. Key Results: The XGBoost ML classifier outperformed (weighted F1 score, MCC, accuracy, ROC-AUC, sensitivity and specificity score of 91.7%, 58.8%, 91.3%, 92.2% 93.8%, and 70.2%, respectively) other models and the SHAP summary plot enabled the identification of significant features that contributes to COVID-19 mortality. These features encompassed comorbidities like renal and cardiac diseases and tuberculosis. Additionally, the XAI models revealed that medications such as enoxaparin, remdesivir, and ivermectin did not exhibit preventive effects on mortality Conclusion and Implications: While XAI models offer valuable insights, they should not replace RCTs as a priority for ensuring the safety and effectiveness of new drugs and treatments. However, XAI models can serve as valuable tools for suggesting future research directions and aiding clinical decision-making, particularly when the efficacy of a drug in a controlled trial is uncertain.

Sudhanshu Mahajan

and 12 more

Objectives: Myocardial injury during active coronavirus disease-2019 (COVID-19) infection is well described however, its persistence during recovery is unclear. We assessed left ventricle (LV) global longitudinal strain (GLS) using speckle tracking echocardiography (STE) in COVID-19 recovered patients and studied its correlation with various parameters.Methods: A total of 134 subjects within 30-45 days post recovery from COVID-19 infection and normal LV ejection fraction were enrolled. Routine blood investigations, inflammatory markers (on admission) and comprehensive echocardiography including STE were done for all. Results: Of the 134 subjects, 121 (90.3%) were symptomatic during COVID-19 illness and were categorized as mild: 61 (45.5%), moderate: 50 (37.3%) and severe: 10 (7.5%) COVID-19 illness. Asymptomatic COVID-19 infection was reported in 13 (9.7%) patients. Subclinical LV and right ventricle (RV) dysfunction were seen in 40 (29.9%) and 14 (10.5%) patients respectively. Impaired LVGLS was reported in 1 (7.7%), 8 (13.1%), 22 (44%) and 9 (90%) subjects with asymptomatic, mild, moderate and severe disease respectively. LVGLS was significantly lower in patients recovered from severe illness (mild: -21 ± 3.4%; moderate: -18.1 ± 6.9%; severe: -15.5 ± 3.1%; P < 0.0001). Subjects with reduced LVGLS had significantly higher interleukin-6 (P < 0.0001), C-reactive protein (P = 0.001), lactate dehydrogenase (P = 0.009) and serum ferritin (P = 0.03) levels during index admission. Conclusions: Subclinical LV dysfunction was seen in nearly a third of recovered COVID-19 patients while 10.5% had RV dysfunction. Our study suggests a need for closer follow-up among COVID-19 recovered subjects to elucidate long-term cardiovascular outcomes.